Human leucocyte antigen-G polymorphisms are associated with cervical squamous cell carcinoma risk in Taiwanese women

European Journal of Cancer

Volumn 50, Issue 2, 2014, Pages 469-474

  Yang, Yuh Cheng ^a,b   Chang, Tzu Yang ^a   Chen, Tze Chien ^a   Lin, Wen Shan ^a   Chang, Shih Chuan ^a   Lee, Yann Jinn ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

Cervical cancer; HLA G; HPV; Immunity; Polymorphism

Indexed keywords

HLA G ANTIGEN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; LEUKOCYTE; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TAIWAN; UNTRANSLATED REGION; UTERINE CERVIX CANCER; WART VIRUS;

EID: 84891826962     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.10.018     Document Type: Article

References (26)

1. A. Jemal, F. Bray, and M.M. Center et al. Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. C.A. Chen, and C.Y. Hsieh Recent advances and problems in primary therapy for cervical cancer in Taiwan J Formos Med Assoc 103 2004 511 518
3. N. Munoz Human papillomavirus and cancer: the epidemiological evidence J Clin Virol 19 2000 1 5
4. T.C. Wu Immunology of the human papilloma virus in relation to cancer Curr Opin Immunol 6 1994 746 754
5. E.D. Carosella, P. Moreau, J. Lemaoult, and N. Rouas-Freiss HLA-G: from biology to clinical benefits Trends Immunol 29 2008 125 132
6. M. Loustau, H. Wiendl, S. Ferrone, and E.D. Carosella HLA-G 2012 conference: the 15-year milestone update Tissue Antigens 81 2013 127 136
7. E.D. Carosella, B. Favier, N. Rouas-Freiss, P. Moreau, and J. Lemaoult Beyond the increasing complexity of the immunomodulatory HLA-G molecule Blood 111 2008 4862 4870
8. B.S. Yoon, Y.T. Kim, and J.W. Kim et al. Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma Int J Gynaecol Obstet 98 2007 48 53
9. N. Zheng, C.X. Wang, and X. Zhang et al. Up-regulation of HLA-G expression in cervical premalignant and malignant lesions Tissue Antigens 77 2011 218 224
10. D.D. Dong, H. Yang, and K. Li et al. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response Reprod Sci 17 2010 718 723
11. X.J. Li, X. Zhang, A. Lin, Y.Y. Ruan, and W.H. Yan Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression Hum Immunol 73 2012 946 949
12. E.A. Donadi, E.C. Castelli, and A. Arnaiz-Villena et al. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association Cell Mol Life Sci 68 2011 369 395
13. R. Ferguson, A.V. Ramanakumar, and H. Richardson et al. Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence Hum Immunol 72 2011 337 341
14. R.T. Simoes, M.A. Goncalves, and E.C. Castelli et al. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus Mod Pathol 22 2009 1075 1082
15. R. Ferguson, A.V. Ramanakumar, and A. Koushik et al. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix Int J Cancer 131 2012 E312 E319
16. I.D. Silva, Y.C. Muniz, and M.C. Sousa et al. HLA-G 3′UTR polymorphisms in high grade and invasive cervico-vaginal cancer Hum Immunol 74 2013 452 458
17. A. Hildesheim, M.H. Schiffman, and P.E. Gravitt et al. Persistence of type-specific human papillomavirus infection among cytologically normal women J Infect Dis 169 1994 235 240
18. A.M. de Roda Husman, J.M. Walboomers, A.J. van den Brule, C.J. Meijer, and P.J. Snijders The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR J Gen Virol 76 Pt 4 1995 1057 1062
19. Y. Zhu, Z. Huo, and J. Lai et al. Case-control study of a HLA-G 14-bp insertion-deletion polymorphism in women with recurrent miscarriages Scand J Immunol 71 2010 52 54
20. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263 265
21. Y.Y. Chen, S.L. You, and C.A. Chen et al. Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences Br J Cancer 101 2009 174 177
22. Z. Tan, G. Randall, and J. Fan et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma Am J Hum Genet 81 2007 829 834
23. P. Rousseau, M. Le Discorde, and G. Mouillot et al. The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability Hum Immunol 64 2003 1005 1010
24. T.V. Hviid, S. Hylenius, C. Rorbye, and L.G. Nielsen HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels Immunogenetics 55 2003 63 79
25. V. Rebmann, K. van der Ven, and M. Passler et al. Association of soluble HLA-G plasma levels with HLA-G alleles Tissue Antigens 57 2001 15 21
26. N. Ghandri, S. Gabbouj, and K. Farhat et al. Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome Hum Immunol 72 2011 150 158